Eye care pharmaceutical company Harrow announced the launch of its next-generation compounded atropine formulations, which are now available at ImprimisRx, its compounding and mail-order pharmacy subsidiary.
According to a Harrow press release, the new formulations can be stored at room temperature for up to 180 days, contain no preservatives or boric acid and have a physiologic pH of 5.5. They have undergone validated testing for consistency, potency and stability.
“Our mission has always been to help our eye care professionals address their patients’ unmet needs and to make